PPT-Treatment of Chronic HCV

with DirectActing Antivirals DAAs wwwhcvguidelinesnyorg Purpose of this Guideline Promote universal screening for HCV Increase the number of NYS residents with chronic HCV infection treated for and cured of HCV . Marie-Louise Vachon, MD, . MSc. Division of . Infectious. . Diseases. Centre Hospitalier Universitaire de Québec. Management of HCV . in Co-Infected Patients. Prevention and counselling. Baseline laboratory testing. Mark Sulkowski, MD . Professor of Medicine. Medical Director, Viral Hepatitis Center. Divisions of Infectious Diseases and Gastroenterology/ Hepatology. Johns Hopkins Medical Institutions. Baltimore Maryland USA. Results from SILEN-C1 in HCV genotype-1 treatment-naïve patients across different baseline factors. Disclosures. Introduction. SILEN-C1 trial. Virologic response. a. Methods. Baseline characteristics. Bruno Spire & Patrizia Carrieri. How to reduce HCV incidence among people who use drugs?. Increasing access to effective treatment for opioïd dependence (e.g. methadone). Diversifying harm reduction tools for safer drug consumption . HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Trial. Phase . 3. Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Treatment. Naïve and Treatment . Experienced. HIV Coinfection. Source: . Sulkowski. MS, et al. JAMA. 2014;312:353-61.. AIDS 2016 | 18-22 July 2016 | Durban, South Africa. Babikhina. . Ksenia. «. Treatment Preparedness Coalition. ». office@itpcru.org. . itpcru.org. Monitoring of drug procurement since 2010, HCV procurement since 2012. Sameh W. Boktor, MD, MPH. Medical Epidemiologist. Pennsylvania Department of Health. Harrisburg, Pennsylvania. Disclosures. Off-label and/or investigational use of pharmaceuticals may be discussed in the presentation. This disclosure is to ensure participants in the activity may formulate their own judgments regarding the presentation.. Program in a Pharmacy Setting. Conveying . the Urgency of . HCV Testing. 1. How to Talk about Hepatitis C Testing. 2. Chronic HCV Infection May Lead to Chronic Liver Disease and Liver Cancer as well as Systemic Disease : DM, Renal Disease, Lymphoma and other problems . IAPAC African Regional Capacity-Building Hub. Based in Johannesburg, South Africa. Mission: Strengthen clinician capacity to deliver HIV, HBV, and HCV treatment . Partners include:. . Supported through an educational grant from: . HepCare Europe No-one gets left behind: addressing the hidden burden of HCV related advanced liver disease in PWID in the community Dr John Lambert, Professor of Medicine and Consultant in Infectious Diseases, Mater Hospital and UCD Dublin Sameh W. Boktor, MD, MPH. Medical Epidemiologist. Pennsylvania Department of Health. Harrisburg, Pennsylvania. Disclosures. Off-label and/or investigational use of pharmaceuticals may be discussed in the presentation. This disclosure is to ensure participants in the activity may formulate their own judgments regarding the presentation.. Todd S. Wills, MD. Martha Friedrich, PhD. SPNS Hepatitis C Treatment Expansion Initiative. University of South Florida. The HIV/HCV Disease Burden. Hepatitis C. In U.S., 4 million HCV+ . →. 85% chronic . Teri Griep-Langholz, RN, HIV/HCV Program Nurse Case Manager. Siouxland Community Health Center. Sioux City, IA . Beyond the Yellow Brick Road—Incorporating HCV into HIV Treatment Model. Learning Objectives. Dr. Sonalika’s Eye Clinic provide the best Eye infection treatment, Conjunctivitis treatment in pune, Hadapsar, Amanora, Magarpatta, Mundhwa, Kharadi Rd, Viman Nagar, Wagholi, and Wadgaon Sheri